ENTERTAINMENT

Anti-inflammatory treatment with arthritis could stop the "storm" of the immune system against the coronavirus


Could an Arthritis Drug Be a Groundbreaking Treatment for Covid? Doctors say that anti-inflammatory treatment could stop the "storm" of the immune system that is responsible for killing thousands

  • Doctors say tocilizumab anti-inflammatory treatment could save lives
  • It could be used to stop the immune system "storm" that killed thousands
  • If successful, it would only be the second drug that has been shown to save lives from the virus

Last night there was hope that an arthritis drug could prove a breakthrough in the treatment of coronavirus.

Doctors say that tocilizumab anti-inflammatory treatment could save lives by stopping the "storm" of the immune system that killed thousands of virus patients.

The results of a large global study are expected this week.

Doctors say that tocilizumab anti-inflammatory treatment could save lives by stopping the "storm" of the immune system that killed thousands of virus patients (file photo)

Doctors are confident that the drug, which was originally developed to treat rheumatoid arthritis, will stop the hyperinflammation that occurs when the immune system attacks the body.

It could drastically reduce deaths from coronaviruses – many of which are caused by the aggressive immune response rather than the virus itself. If successful, it would only be the second drug that has been shown to save lives from the virus. So far, only the steroid dexamethasone has proven itself.

The researchers believe that a variety of Covid-19 treatments are needed to make the biggest difference, so doctors can use medication for certain problems.

Treatment could drastically reduce deaths from coronaviruses - many of which are caused by the aggressive immune response rather than the virus itself (file photo)

Treatment could drastically reduce deaths from coronaviruses – many of which are caused by the aggressive immune response rather than the virus itself (file photo)

450 virus patients around the world participated in the study.

The Swiss drug giant Roche is doing the treatment. The doctors hope for a positive result. Dr. Taryn Youngstein from Imperial College London, who was involved in the study, said: "It is very clear that the main form of Covid that kills people is related to … the body's response to the virus, not the virus self." We have to think about how we can suppress this reaction. "

Tocilizumab has also been used to minimize the risk to cancer patients undergoing risky T cell therapy. Dr. Youngstein added: “We are very familiar with the drug. We know that it is very safe and very well tolerated. The question is whether it works in Covid-19. "

An earlier Italian study indicated that the number of deaths could be reduced by up to 39 percent. However, it was not a so-called randomized control study, so the results were not conclusive.

advertising

(tagsToTranslate) Dailymail (t) Health (t) Coronavirus